AI Assistant
Blog
Pricing
Log In
Sign Up
Anti-α-glucose–based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
